Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Abbott presents new Bcl-targeting agents with potential in cancer chemotherapy

Aug. 18, 2004

FDA and Genentech issue warning on Avastin

Aug. 18, 2004

New HSP90 inhibitors and their use in cancer and other disorders

Aug. 18, 2004

Swiss approval for Femara as extended adjuvant treatment

Aug. 18, 2004

Combined immunostimulatory treatment enhances antitumor activity in vivo

Aug. 18, 2004

NeuroSearch and TopoTarget collaborate on Endovion development

Aug. 17, 2004

Spectrum acquires North American, Indian rights to D-631153

Aug. 17, 2004

Novartis exercises option to Vernalis' lead Hsp90 oncology program

Aug. 16, 2004

Pharmacia presents new CDK inhibitors

Aug. 16, 2004

European orphan drug designation for TheraCIM hR3

Aug. 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...